Suppr超能文献

相似文献

1
The role of aflatoxins in hepatocellular carcinoma.
Hepat Mon. 2012 Oct;12(10 HCC):e7238. doi: 10.5812/hepatmon.7238. Epub 2012 Oct 11.
4
Challenging Role of Dietary Aflatoxin B1 Exposure and Hepatitis B Infection on Risk of Hepatocellular Carcinoma.
Open Access Maced J Med Sci. 2015 Jun 15;3(2):363-9. doi: 10.3889/oamjms.2015.032. Epub 2015 Mar 25.
7
Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
Mutat Res. 2008 Jul-Aug;659(1-2):176-84. doi: 10.1016/j.mrrev.2008.01.005. Epub 2008 Jan 20.
8
A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention.
Cancer Lett. 2009 Dec 1;286(1):22-8. doi: 10.1016/j.canlet.2009.02.053. Epub 2009 Apr 2.
9
TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1638-43. doi: 10.1158/1055-9965.EPI-08-1102. Epub 2009 Apr 14.
10
Hepatocellular carcinoma: from gene to public health.
J Natl Cancer Inst. 1997 Dec 17;89(24):1844-51. doi: 10.1093/jnci/89.24.1844.

引用本文的文献

2
Modelling epidemiological and economics processes - the case of cervical cancer.
Health Econ Rev. 2025 Feb 22;15(1):13. doi: 10.1186/s13561-024-00589-1.
3
Digestive cancers: mechanisms, therapeutics and management.
Signal Transduct Target Ther. 2025 Jan 15;10(1):24. doi: 10.1038/s41392-024-02097-4.
5
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment.
Clin Mol Hepatol. 2025 Feb;31(Suppl):S228-S254. doi: 10.3350/cmh.2024.0824. Epub 2024 Dec 26.
8
Role of Immunological Cells in Hepatocellular Carcinoma Disease and Associated Pathways.
ACS Pharmacol Transl Sci. 2023 Nov 8;6(12):1801-1816. doi: 10.1021/acsptsci.3c00216. eCollection 2023 Dec 8.
10
Inhibition of Cancer Development by Natural Plant Polyphenols: Molecular Mechanisms.
Int J Mol Sci. 2023 Jun 26;24(13):10663. doi: 10.3390/ijms241310663.

本文引用的文献

2
Role of aflatoxin B1 as a risk for primary liver cancer in north Indian population.
Clin Biochem. 2011 Oct;44(14-15):1235-40. doi: 10.1016/j.clinbiochem.2011.07.017. Epub 2011 Aug 10.
3
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
6
Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
Pathol Biol (Paris). 2010 Aug;58(4):273-7. doi: 10.1016/j.patbio.2010.01.005. Epub 2010 Apr 7.
7
Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.
Environ Health Perspect. 2010 Jun;118(6):818-24. doi: 10.1289/ehp.0901388. Epub 2010 Feb 19.
8
XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk.
BMC Cancer. 2009 Nov 17;9:400. doi: 10.1186/1471-2407-9-400.
9
Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan.
Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):846-53. doi: 10.1158/1055-9965.EPI-08-0697.
10
The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China.
Ann Epidemiol. 2008 Jul;18(7):572-8. doi: 10.1016/j.annepidem.2008.03.003. Epub 2008 May 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验